A study of small RNAs from cerebral neocortex of pathology-verified Alzheimer's disease, dementia with lewy bodies, hippocampal sclerosis, frontotemporal lobar dementia, and non-demented human controls.

MicroRNAs (miRNAs) are small (20-22 nucleotides) regulatory non-coding RNAs that strongly influence gene expression. Most prior studies addressing the role of miRNAs in neurodegenerative diseases (NDs) have focused on individual diseases such as Alzheimer's disease (AD), making disease-to-disease comparisons impossible. Using RNA deep sequencing, we sought to analyze in detail the small RNAs (including miRNAs) in the temporal neocortex gray matter from non-demented controls (n = 2), AD (n = 5), dementia with Lewy bodies (n = 4), hippocampal sclerosis of aging (n = 4), and frontotemporal lobar dementia (FTLD) (n = 5) cases, together accounting for the most prevalent ND subtypes. All cases had short postmortem intervals, relatively high-quality RNA, and state-of-the-art neuropathological diagnoses. The resulting data (over 113 million reads in total, averaging 5.6 million reads per sample) and secondary expression analyses constitute an unprecedented look into the human cerebral cortical miRNome at a nucleotide resolution. While we find no apparent changes in isomiR or miRNA editing patterns in correlation with ND pathology, our results validate and extend previous miRNA profiling studies with regard to quantitative changes in NDs. In agreement with this idea, we provide independent cohort validation for changes in miR-132 expression levels in AD (n = 8) and FTLD (n = 14) cases when compared to controls (n = 8). The identification of common and ND-specific putative novel brain miRNAs and/or short-hairpin molecules is also presented. The challenge now is to better understand the impact of these and other alterations on neuronal gene expression networks and neuropathologies.

[1]  K. Heilman,et al.  Relative Frequencies of Alzheimer Disease, Lewy Body, Vascular and Frontotemporal Dementia, and Hippocampal Sclerosis in the State of Florida Brain Bank , 2002, Alzheimer disease and associated disorders.

[2]  Ryan T Fuchs,et al.  Structural bias in T4 RNA ligase-mediated 3′-adapter ligation , 2012, Nucleic acids research.

[3]  Paul Bertone,et al.  Systematic comparison of microarray profiling, real-time PCR, and next-generation sequencing technologies for measuring differential microRNA expression. , 2010, RNA.

[4]  Thierry Arnould,et al.  miR-212/132 expression and functions: within and beyond the neuronal compartment , 2012, Nucleic acids research.

[5]  Jeremy J. W. Chen,et al.  Unique MicroRNA signature and clinical outcome of cancers. , 2007, DNA and cell biology.

[6]  M. McPeek,et al.  MicroRNAs and metazoan macroevolution: insights into canalization, complexity, and the Cambrian explosion , 2009, BioEssays : news and reviews in molecular, cellular and developmental biology.

[7]  Monica Driscoll,et al.  MicroRNAs in C. elegans Aging: Molecular Insurance for Robustness? , 2009, Current genomics.

[8]  A. Delacourte,et al.  Loss of microRNA cluster miR-29a/b-1 in sporadic Alzheimer's disease correlates with increased BACE1/β-secretase expression , 2008, Proceedings of the National Academy of Sciences.

[9]  J. Mattick,et al.  Noncoding RNAs and RNA editing in brain development, functional diversification, and neurological disease. , 2007, Physiological reviews.

[10]  W. Lukiw,et al.  Micro-RNA speciation in fetal, adult and Alzheimer's disease hippocampus , 2007, Neuroreport.

[11]  E. Ullian,et al.  A role for noncanonical microRNAs in the mammalian brain revealed by phenotypic differences in Dgcr8 versus Dicer1 knockouts and small RNA sequencing. , 2011, RNA.

[12]  Yuhai Zhao,et al.  Characterization of an NF-kappaB-regulated, miRNA-146a-mediated down-regulation of complement factor H (CFH) in metal-sulfate-stressed human brain cells. , 2009, Journal of inorganic biochemistry.

[13]  A. Delacourte,et al.  MicroRNA regulation of Alzheimer's Amyloid precursor protein expression , 2009, Neurobiology of Disease.

[14]  J. Keller,et al.  RNA in Brain Disease: No Longer Just "The Messenger in the Middle" , 2007, Journal of neuropathology and experimental neurology.

[15]  J. Satoh,et al.  Aberrant microRNA expression in the brains of neurodegenerative diseases: miR‐29a decreased in Alzheimer disease brains targets neurone navigator 3 , 2010, Neuropathology and applied neurobiology.

[16]  N. Arora,et al.  Interaction Map and Selection of microRNA Targets in Parkinson's Disease-Related Genes , 2009, Journal of biomedicine & biotechnology.

[17]  N. Miller,et al.  Identification of suitable endogenous control genes for microRNA gene expression analysis in human breast cancer , 2008, BMC Molecular Biology.

[18]  Peter T. Nelson,et al.  Patterns of microRNA expression in normal and early Alzheimer’s disease human temporal cortex: white matter versus gray matter , 2011, Acta Neuropathologica.

[19]  Debomoy K Lahiri,et al.  MicroRNA-101 downregulates Alzheimer's amyloid-β precursor protein levels in human cell cultures and is differentially expressed. , 2011, Biochemical and biophysical research communications.

[20]  Eduardo Gascon,et al.  Cause or Effect: Misregulation of microRNA Pathways in Neurodegeneration , 2012, Front. Neurosci..

[21]  Yvonne Tay,et al.  A Pattern-Based Method for the Identification of MicroRNA Binding Sites and Their Corresponding Heteroduplexes , 2006, Cell.

[22]  Na Li,et al.  Comprehensive survey of human brain microRNA by deep sequencing , 2010, BMC Genomics.

[23]  B. Ray,et al.  MicroRNA-153 Physiologically Inhibits Expression of Amyloid-β Precursor Protein in Cultured Human Fetal Brain Cells and Is Dysregulated in a Subset of Alzheimer Disease Patients* , 2012, The Journal of Biological Chemistry.

[24]  Ana Kozomara,et al.  miRBase: integrating microRNA annotation and deep-sequencing data , 2010, Nucleic Acids Res..

[25]  L. Buée,et al.  MicroRNA-132 loss is associated with tau exon 10 inclusion in progressive supranuclear palsy , 2011, Alzheimer's & Dementia.

[26]  P. Nelson,et al.  Technical variables in high-throughput miRNA expression profiling: much work remains to be done. , 2008, Biochimica et biophysica acta.

[27]  P. Nelson,et al.  Studying microRNAs in the brain: Technical lessons learned from the first ten years , 2012, Experimental Neurology.

[28]  M. Sur,et al.  miR-132, an experience-dependent microRNA, is essential for visual cortex plasticity. , 2011, Nature neuroscience.

[29]  E. Wang,et al.  MicroRNA group disorganization in aging , 2010, Experimental Gerontology.

[30]  S. Luo,et al.  RNA-ligase-dependent biases in miRNA representation in deep-sequenced small RNA cDNA libraries. , 2011, RNA.

[31]  David L. A. Wood,et al.  MicroRNAs and their isomiRs function cooperatively to target common biological pathways , 2011, Genome Biology.

[32]  Charles D. Smith,et al.  Brains With Medial Temporal Lobe Neurofibrillary Tangles But No Neuritic Amyloid Plaques Are a Diagnostic Dilemma But May Have Pathogenetic Aspects Distinct From Alzheimer Disease , 2009, Journal of neuropathology and experimental neurology.

[33]  Xavier Estivill,et al.  MicroRNA profiling of Parkinson's disease brains identifies early downregulation of miR-34b/c which modulate mitochondrial function. , 2011, Human molecular genetics.

[34]  Kirandeep Kaur,et al.  Cellular Physiology Cellular Physiology Cellular Physiology Cellular Physiology Cellular Physiology Micrornas in Diabetes: Tiny Players in Big Disease , 2022 .

[35]  Peter T Nelson,et al.  The miR-15/107 group of microRNA genes: evolutionary biology, cellular functions, and roles in human diseases. , 2010, Journal of molecular biology.

[36]  King-Hwa Ling,et al.  Deep sequencing analysis of the developing mouse brain reveals a novel microRNA , 2011, BMC Genomics.

[37]  D. Bennett,et al.  The neuropathology of older persons with and without dementia from community versus clinic cohorts. , 2009, Journal of Alzheimer's disease : JAD.

[38]  Peter T. Nelson,et al.  MicroRNAs (miRNAs) in Neurodegenerative Diseases , 2008, Brain pathology.

[39]  J. Mattick,et al.  Noncoding RNAs in Long-Term Memory Formation , 2008, The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry.

[40]  Yi Xing,et al.  The Bifunctional microRNA miR-9/miR-9* Regulates REST and CoREST and Is Downregulated in Huntington's Disease , 2008, The Journal of Neuroscience.

[41]  L. O’Neill Boosting the brain's ability to block inflammation via microRNA-132. , 2009, Immunity.

[42]  J. Trojanowski,et al.  TMEM106B, the Risk Gene for Frontotemporal Dementia, Is Regulated by the microRNA-132/212 Cluster and Affects Progranulin Pathways , 2012, The Journal of Neuroscience.

[43]  P. Nelson,et al.  In situ hybridization is a necessary experimental complement to microRNA (miRNA) expression profiling in the human brain , 2009, Neuroscience Letters.

[44]  S. Hébert,et al.  miRNAs in Neurodegeneration , 2007, Science.

[45]  Guiliang Tang,et al.  The Expression of MicroRNA miR-107 Decreases Early in Alzheimer's Disease and May Accelerate Disease Progression through Regulation of β-Site Amyloid Precursor Protein-Cleaving Enzyme 1 , 2008, The Journal of Neuroscience.

[46]  Munafó Db,et al.  Optimization of enzymatic reaction conditions for generating representative pools of cDNA from small RNA , 2010 .

[47]  P. Nelson,et al.  MiR-107 is reduced in Alzheimer's disease brain neocortex: validation study. , 2010, Journal of Alzheimer's disease : JAD.

[48]  B. H. Miller,et al.  MicroRNA-132 dysregulation in schizophrenia has implications for both neurodevelopment and adult brain function , 2012, Proceedings of the National Academy of Sciences.

[49]  G. Hannon,et al.  A MicroRNA Feedback Circuit in Midbrain Dopamine Neurons , 2007, Science.

[50]  P. Falkai,et al.  microRNA‐34c is a novel target to treat dementias , 2011, The EMBO journal.

[51]  Xavier Estivill,et al.  A myriad of miRNA variants in control and Huntington’s disease brain regions detected by massively parallel sequencing , 2010, Nucleic acids research.

[52]  Kenneth S. Kosik,et al.  Deep annotation of mouse iso-miR and iso-moR variation , 2012, Nucleic acids research.

[53]  H. Hirase,et al.  miRNA profiling of bilateral rat hippocampal CA3 by deep sequencing. , 2011, Biochemical and biophysical research communications.

[54]  S. Rapoport,et al.  Biomarkers and evolution in Alzheimer disease , 2011, Progress in Neurobiology.

[55]  Peter T Nelson,et al.  Clinicopathologic Correlations in a Large Alzheimer Disease Center Autopsy Cohort: Neuritic Plaques and Neurofibrillary Tangles "Do Count" When Staging Disease Severity , 2007, Journal of neuropathology and experimental neurology.

[56]  N. Amariglio,et al.  A-to-I RNA editing: a new regulatory mechanism of global gene expression. , 2007, Blood cells, molecules & diseases.

[57]  R. Plasterk,et al.  RAKE and LNA-ISH reveal microRNA expression and localization in archival human brain. , 2005, RNA.

[58]  M. Lachmann,et al.  MicroRNA, mRNA, and protein expression link development and aging in human and macaque brain. , 2010, Genome research.

[59]  Selene L. Fernandez-Valverde,et al.  Dynamic isomiR regulation in Drosophila development. , 2010, RNA.

[60]  W. Lukiw,et al.  Induction of specific micro RNA (miRNA) species by ROS-generating metal sulfates in primary human brain cells. , 2007, Journal of inorganic biochemistry.

[61]  C. Angelini,et al.  Overexpression of microRNA-206 in the skeletal muscle from myotonic dystrophy type 1 patients , 2010, Journal of Translational Medicine.

[62]  Ana Kozomara,et al.  Reducing ligation bias of small RNAs in libraries for next generation sequencing , 2012, Silence.

[63]  B. Kaczkowski,et al.  How the RNA isolation method can affect microRNA microarray results. , 2011, Acta biochimica Polonica.

[64]  A. Cristino,et al.  Deep Sequencing of Organ- and Stage-Specific microRNAs in the Evolutionarily Basal Insect Blattella germanica (L.) (Dictyoptera, Blattellidae) , 2011, PloS one.

[65]  L. Buée,et al.  MicroRNAs and the Regulation of Tau Metabolism , 2012, International journal of Alzheimer's disease.

[66]  C. Burge,et al.  Most mammalian mRNAs are conserved targets of microRNAs. , 2008, Genome research.

[67]  Daniela C. Zarnescu,et al.  Biochemical and genetic interaction between the fragile X mental retardation protein and the microRNA pathway , 2004, Nature Neuroscience.

[68]  Juan Nunez-Iglesias,et al.  Joint Genome-Wide Profiling of miRNA and mRNA Expression in Alzheimer's Disease Cortex Reveals Altered miRNA Regulation , 2010, PloS one.

[69]  S. Hébert,et al.  Alterations of the microRNA network cause neurodegenerative disease , 2009, Trends in Neurosciences.

[70]  Hippocampal microRNA-132 mediates stress-inducible cognitive deficits through its acetylcholinesterase target , 2012, Brain Structure and Function.

[71]  A. Roses,et al.  Identification of miRNA Changes in Alzheimer's Disease Brain and CSF Yields Putative Biomarkers and Insights into Disease Pathways , 2008 .

[72]  H. Geekiyanage,et al.  MicroRNA-137/181c Regulates Serine Palmitoyltransferase and In Turn Amyloid β, Novel Targets in Sporadic Alzheimer's Disease , 2011, The Journal of Neuroscience.

[73]  Walter J. Lukiw,et al.  Micro-RNA abundance and stability in human brain: Specific alterations in Alzheimer's disease temporal lobe neocortex , 2009, Neuroscience Letters.

[74]  S. Hébert,et al.  In vivo regulation of amyloid precursor protein neuronal splicing by microRNAs , 2011, Journal of neurochemistry.

[75]  C. Stephan,et al.  Robust microRNA stability in degraded RNA preparations from human tissue and cell samples. , 2010, Clinical chemistry.

[76]  Peter T Nelson,et al.  Focus on RNA isolation: obtaining RNA for microRNA (miRNA) expression profiling analyses of neural tissue. , 2008, Biochimica et biophysica acta.